A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity.
Jacob F, Salinas RD, Zhang DY, Nguyen PTT, Schnoll JG, Wong SZH, Thokala R, Sheikh S, Saxena D, Prokop S, Liu DA, Qian X, Petrov D, Lucas T, Chen HI, Dorsey JF, Christian KM, Binder ZA, Nasrallah M, Brem S, O'Rourke DM, Ming GL, Song H.
Cell. 2020 Jan 9;180(1):188-204.e22. doi: 10.1016/j.cell.2019.11.036. Epub 2019 Dec 26.
PMID:31883794
Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies.
Hamad A, Yusubalieva GM, Baklaushev VP, Chumakov PM, Lipatova AV.
Viruses. 2023 Feb 16;15(2):547. doi: 10.3390/v15020547.
PMID:36851761
Glioblastoma and other malignant gliomas: a clinical review.
Omuro A, DeAngelis LM.
JAMA. 2013 Nov 6;310(17):1842-50. doi: 10.1001/jama.2013.280319.
PMID:24193082
A comprehensive profile of recurrent glioblastoma.
Campos B, Olsen LR, Urup T, Poulsen HS.
Oncogene. 2016 Nov 10;35(45):5819-5825. doi: 10.1038/onc.2016.85. Epub 2016 Apr 4.
PMID:27041580
Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer.
Gimple RC, Bhargava S, Dixit D, Rich JN.
Genes Dev. 2019 Jun 1;33(11-12):591-609. doi: 10.1101/gad.324301.119.
PMID:31160393
The definition of primary and secondary glioblastoma.
Ohgaki H, Kleihues P.
Clin Cancer Res. 2013 Feb 15;19(4):764-72. doi: 10.1158/1078-0432.CCR-12-3002. Epub 2012 Dec 3.
PMID:23209033
Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma.
Wu H, Guo C, Wang C, Xu J, Zheng S, Duan J, Li Y, Bai H, Xu Q, Ning F, Wang F, Yang Q.
Cancer Sci. 2023 Jun;114(6):2609-2621. doi: 10.1111/cas.15773. Epub 2023 Mar 10.
PMID:36853018
Glioblastoma and brain connectivity: the need for a paradigm shift.